Expression of CD44, but not CD44v6, predicts relapse in children with B cell progenitor acute lymphoblastic leukemia lacking adverse or favorable genetics

References

• Conter V, Arico M, Valsecchi M, Basso G, Biondi A, Madon E, et al. Long-term results of the Italian Association of Pediatric Hematology and Oncology (AIEOP) acute lymphoblastic leukemia studies, 1982 – 1995. Leukemia 2000; 14: 2196–2204
   PubMed Web of Science ®Google Scholar
• Balduzzi A, Valsecchi M, Uderzo C, De Lorenzo P, Klingebiel T, Peters C, et al. Chemotherapy versus allogeneic transplantation for very-high-risk childhood acute lymphoblastic leukaemia in first complete remission: comparison by genetic randomisation in an international prospective study. Lancet 2005; 366: 635–642
   PubMed Web of Science ®Google Scholar
• Caglar K, Varan A, Akyuz C, Selek U, Kutluk T, Yalcin B, et al. Second neoplasms in pediatric patients treated for cancer: a center's 30-year experience. J Pediatr Hematol Oncol 2006; 28: 374–378
   PubMed Web of Science ®Google Scholar
• Reddick W, Shan Z, Glass J, Helton S, Xiong X, Wu S, et al. Smaller white-matter volumes are associated with larger deficits in attention and learning among long-term survivors of acute lymphoblastic leukemia. Cancer 2006; 106: 941–949
   PubMed Web of Science ®Google Scholar
• Smith M, Arthur D, Camitta B, Carroll A, Crist W, Gaynon P, et al. Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia. J Clin Oncol 1996; 14: 18–24
   PubMed Web of Science ®Google Scholar
• Bendall L, Gottlieb D. CD44 and adhesion of normal and leukaemic CD34+ cells to bone marrow stroma. Leuk Lymphoma 1999; 32: 427–439
   PubMed Web of Science ®Google Scholar
• Miyake K, Medina K L, Hayashi S-I, Ono S, Hamaoka T, Kincade P W. Monoclonal antibodies to Pgp-1/CD44 block lymphohemopoiesis in long-term bone marrow cultures. J Exp Med 1990; 171: 477–488
   PubMed Web of Science ®Google Scholar
• Schmits R, Filmus J, Gerwin N, Senaldi G, Kiefer F, Kundig T, et al. CD44 regulates hematopoietic progenitor distribution, granuloma formation, and tumorigenicity. Blood 1997; 90: 2217–2233
   PubMed Web of Science ®Google Scholar
• Screaton G, Bell M, Jackson D, Cornelis F, Gerth U, Bell J. Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci USA 1992; 89: 12160–12164
   PubMed Web of Science ®Google Scholar
• Ghaffari S, Dougherty G, Lansdorp P, Eaves A, Eaves C. Differentiation-associated changes in CD44 isoform expression during normal hematopoiesis and their alteration in chronic myeloid leukemia. Blood 1995; 86: 2976–2985
   PubMed Web of Science ®Google Scholar
• Neu S, Geiselhart A, Sproll M, Hahn D, Kuci S, Niethammer D, et al. Expression of CD44 isoforms by highly enriched CD34-positive cells in cord blood, bone marrow and leukaphereses. Bone Marrow Transplant 1997; 20: 593–598
   PubMed Web of Science ®Google Scholar
• Yamamichi K, Uehara Y, Kitamura N, Nakane Y, Hioki K. Increased expression of CD44v6 mRNA significantly correlates with distant metastasis and poor prognosis in gastric cancer. Int J Cancer 1998; 79: 256–262
   PubMed Web of Science ®Google Scholar
• Tempfer C, Lösch A, Heinzel H, Häusler G, Hanzal E, Kölbl H, et al. Prognostic value of immunohistochemically detected CD44 isoforms CD44v5, CD44v6 and CD44v7-8 in human breast cancer. Eur J Cancer 1996; 32A: 2023–2025
   PubMed Web of Science ®Google Scholar
• Mulder J-W, Kruyt P, Sewnath M, Oosting J, Seldenrijk C, Weidema W, et al. Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins. Lancet 1994; 344: 1470–1472
   PubMed Web of Science ®Google Scholar
• Hoshimoto K, Yamauchi N, Takazawa Y, Onda T, Taketani Y, Fukayama M. CD44 variant 6 in endometrioid carcinoma of the uterus: its expression in the adenocarcinoma component is an independent prognostic marker. Pathol Res Pract 2003; 199: 71–77
   PubMed Web of Science ®Google Scholar
• Concin N, Hefler L, van Bavel J, Mueller-Holzner E, Zeimet A, Daxenbichler G, et al. Biological markers in pT1 and pT2 ovarian cancer with lymph node metastases. Gynecol Oncol 2003; 89: 9–15
   PubMed Web of Science ®Google Scholar
• Miyoshi T, Kondo K, Hino N, Uyama T, Monden Y. The expression of the CD44 variant exon 6 is associated with lymph node metastasis in non-small cell lung cancer. Clin Cancer Res 1997; 3: 1289–1297
   PubMed Web of Science ®Google Scholar
• Legras S, Günthert U, Stauder R, Curt F, Oliferenko S, Kluin-Nelemans H, et al. A strong expression of CD44-6v correlates with shorter survival of patients with acute myeloid leukemia. Blood 1998; 91: 3401–3413
   PubMed Web of Science ®Google Scholar
• Stauder R, Eisterer W, Thaler J, Gunthert U. CD44 variant isoforms in non-Hodgkin's lymphoma: a new independent prognostic factor. Blood 1995; 85: 2885–2899
   PubMed Web of Science ®Google Scholar
• Stauder R, Van Driel M, Schwarzler C, Thaler J, Lokhorst H, Kreuser E, et al. Different CD44 splicing patterns define prognostic subgroups in multiple myeloma. Blood 1996; 88: 3101–3108
   PubMed Web of Science ®Google Scholar
• Willman C, Kang H, Potter J, Harvey R, Atlas S, Bedrick E, . A gene expression classifier for improved risk classification and outcome prediction in pediatric acute lymphoblastic leukemia (ALL). Blood, J Shattil, et al. Georgia, Atlanta, 762, American Society of Hematology 2005
   Google Scholar
• Magyarosy E, Sebestyen A, Timar J. Expression of metastasis associated proteins, CD44v6 and NM23-H1, in pediatric acute lymphoblastic leukemia. Anticancer Res 2001; 21: 819–823
   PubMed Web of Science ®Google Scholar
• Bendall L, Nilsson S, Khan N, James A, Bonnet C, Lock R, et al. Role of CD44 variant exon 6 in acute lymphoblastic leukaemia: association with altered bone marrow localisation and increased tumour burden. Leukemia 2004; 18: 1308–1311
   PubMed Web of Science ®Google Scholar
• Kortlepel K, Bendall L J, Gottlieb D J. Human acute myeloid leukemia cells express adhesion proteins and bind to bone marrow fibroblast monolayers and extracellular matrix proteins. Leukemia 1993; 7: 1174–1179
   PubMed Web of Science ®Google Scholar
• Vaskova M, Mejstrikova E, Kalina T, Martinkova P, Omelka M, Trka J, et al. Transfer of genomics information to flow cytometry: expression of CD27 and CD44 discriminates subtypes of acute lymphoblastic leukemia. Leukemia 2005; 19: 876–878
   PubMed Web of Science ®Google Scholar
• Yeoh E, Ross M, Shurtleff S, Williams W, Patel D, Mahfouz R, et al. Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell 2002; 1: 133–143
   PubMed Web of Science ®Google Scholar
• Willenbrock H, Juncker A, Schmiegelow K, Knudsen S, Ryder L. Prediction of immunophenotype, treatment response, and relapse in childhood acute lymphoblastic leukemia using DNA microarrays. Leukemia 2004; 18: 1270–1277
   PubMed Web of Science ®Google Scholar
• Ross M, Zhou X, Song G, Shurtleff S, Girtman K, Williams W, et al. Classification of pediatric acute lymphoblastic leukemia by gene expression profiling. Blood 2003; 102: 2951–2959
   PubMed Web of Science ®Google Scholar
• Uckun F, Sensel M, Sather H, Gaynon P, Arthur D, Lange B, et al. Clinical significance of translocation t(1;19) in childhood acute lymphoblastic leukemia in the context of contemporary therapies: a report from the Children's Cancer Group. J Clin Oncol 1998; 16: 527–535
   PubMed Web of Science ®Google Scholar
• Takeuchi M, Tanizawa A, Fukumoto Y, Kikawa Y, Mayumi M. Serum soluble CD44 in pediatric patients with acute leukemia. J Pediatr Hematol Oncol 1999; 21: 384–388
   PubMed Web of Science ®Google Scholar
• Nasu H, Hibi N, Ohyashiki J, Hara A, Kubono K, Tsukada Y, et al. Serum soluble CD44 levels for monitoring disease states in acute leukemia and myelodysplastic syndromes. Int J Oncol 1998; 13: 525–530
   PubMed Web of Science ®Google Scholar
• Yokota A, Ishii G, Sugaya Y, Nishimura M, Saito Y, Harigaya K. Potential use of serum CD44 as an indicator of tumour progression in acute leukemia. Hematol Oncol 1999; 17: 161–168
   PubMed Web of Science ®Google Scholar
• Tacyildiz N, Cavdar A, Yavuz G, Gozdasoglu S, Unal E, Ertem U, et al. Serum levels and differential expression of CD44 in childhood leukemia and malignant lymphoma: correlation with prognostic criteria and survival. Pediatr Int 2001; 43: 354–360
   PubMed Web of Science ®Google Scholar
• Mengarelli A, Zarcone D, Caruso R, Tenca C, Rana I, Pinto R, et al. Adhesion molecule expression, clinical features and therapy outcome in childhood acute lymphoblastic leukemia. Leuk Lymphoma 2001; 40: 625–630
   PubMed Web of Science ®Google Scholar